(19)

(11)

EP 4 573 085 A1

(12)

(43) Date of publication: 25.06.2025 Bulletin 2025/26 (21) Application number: 23764707.8 (22) Date of filing: 15.08.2023

(51) International Patent Classification (IPC):  C07D 401/12(2006.01) A61K 31/4412(2006.01) A61P 35/00(2006.01) (52) Cooperative Patent Classification (CPC): C07D 401/12; A61P 35/00 (86) International application number: PCT/IB2023/058197 (87) International publication number: WO 2024/038378 (22.02.2024 Gazette 2024/08)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 16.08.2022 IN 202221046493 (71) Applicant: Glenmark Pharmaceuticals Limited Mumbai 400 026 (IN)

(72) Inventors: CHINNAPATTU, Murugan Mumbai 400709 (IN) CHAUDHARI, Sachin Mumbai 400709 (IN) GOWDA, Nagaraj Mumbai 400709 (IN) DAS, Sanjib Mumbai 400709 (IN) IYER, Pravin Mumbai 400709 (IN) WAGHMARE, Nayan Mumbai 400709 (IN) SHELKE, Sandeep Mumbai 400709 (IN) GAVHANE, Balasaheb Mumbai 400709 (IN) SAINI, Jagmohan Mumbai 400709 (IN) KADAM, Sheetal Mumbai 400709 (IN) (74) Representative: Nederlandsch Octrooibureau  P.O. Box 29720 2502 LS The Hague 2502 LS The Hague (NL)